chrisvoncsefalvay/vaers-outcomes huggingface dataset:
first shot began electric shocks in lower back; This is a spontaneous report from a contactable consumer (patient). The 67-years-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 02Mar2021 13:30 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. Medical history included concussion 8 years ago. The patient's concomitant medications were not reported.  The patient experienced first shot began electric shocks in lower back on an unknown date. The patient underwent lab tests and procedures which included Nasal Swab on 10May2021 and result was negative. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
On 20 Aug 21 I began feeling heart attack like symptoms to include heart palpitations, shortness of breath, and pain radiating down my left arm. I went to the Emergency Room who transferred me to another Hospital for admittance. Since being discharged I have received a prescription for Ramipril and have not received any other prescriptions or treatment.
Freezing cold to the point of shivering and teeth chattering - chills, headache, body ache, fogginess, extreme fatigue.  Tylenol every 6 hours.  Cold packs on head and neck.  All except headache went away by Friday, 2/26/2021.
Received Hep B #1.  Fever of 102 following day. 9/5/07-records received for DOS 8/2-8/3/07-Admitting diagnosis Fever. Baby fussy did not want to breast feed, temp 102 axillary.
Very sore eyes; This is a spontaneous report received from a non-contactable consumer, the patient. A 55-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on 18Mar2021 (at the age of 55-year-old) as a single dose, for COVID-19 immunisation. Medical history included asthma. The patient was allergic to penicillin. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On an unknown date in Mar2021, the patient had very sore eyes. It was unknown if the patient receive treatment for the adverse event. The clinical outcome of very sore eyes was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.  Amendment: This follow-up report is being submitted to amend previously reported information: Patient country added in patient tab; Verbatim of Relevant Med History updated from "Penicillin allergy" to "known allergies: penicillin", note added and Final sentence was updated as "No follow-up attempts are needed; information about lot/batch number cannot be obtained".
NEUROLOGICAL DAMAGE IN ONE ARM; This spontaneous report received from a consumer by a Business partner on 07-DEC-2021 was received on 08-DEC-2021 and concerned a male of unspecified age, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: Unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination (Dose number series 1). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 07-DEC-2021, the patient experienced neurological damage in one arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of neurological damage in one arm was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0.20211221968-covid-19 vaccine ad26.cov2.s -Neurological damage in one arm. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Fever 100; Chills; headache; body aches; fever of 101.3; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm), PAIN (body aches), PYREXIA (fever of 101.3), PYREXIA (Fever 100) and CHILLS (Chills) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). On 04-Apr-2021, the patient experienced PYREXIA (fever of 101.3). On 05-Apr-2021, the patient experienced PAIN (body aches) and HEADACHE (headache). On 14-Apr-2021, the patient experienced CHILLS (Chills). On 15-Apr-2021, the patient experienced PYREXIA (Fever 100). At the time of the report, PAIN IN EXTREMITY (Pain in arm), PAIN (body aches), PYREXIA (fever of 101.3), PYREXIA (Fever 100), CHILLS (Chills) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Apr-2021, Body temperature: 101.3 (abnormal) fever:101.3. On 05-Apr-2021, Body temperature: 100 (abnormal) fever:100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No corrective treatment was reported.
Delayed injection site rash. Just started today, not painful but slightly raised and warm to the touch.
This spontaneous report as received from a approximately 88 year old male patient with penicillin allergy. The patient currently had a implant pacemaker. Approximately in May 2010 (reported as 3-4 years ago) the patient was vaccinated with ZOSTAVAX injection. Concomitant therapies included warfarin (manufacturer unknown) 1 milligram (mg) 2 1/2 tablets a day, bisoprolol Fum (manufacturer unknown) tablets 5 mg 1/2 tablet a day, CARTIA 180 mg takes 1 capsule, torsemide (manufacturer unknown) 20 mg and potassium (manufacturer unknown) 10 mg. Approximately in March 2014 (reported as 2 months ago) the patient came down with shingles 2 months ago which lasted a couple of weeks, since then shingles have gone away. On 13-MAY-2014, the blood test was conducted to determine for blood thinner. The outcome of came down with shingles 2 months ago which lasted a couple of weeks was reported as recovered/resolved (reported as gone away). The causality was not reported. It was reported as the patient sought the medical attention. Additional information has been requested.
Sore arm, chills, muscle soreness for about 18 hours. Heavier and long than usual menstrual cycle. I would describe the menstruation as very heavy, soaking through three pads in one night. Lasting three days. This occurred with my second dose vaccination as well.
Difficulty speaking and thinking clearly, unable to carry on a conversation/ finish a thought process, lasted until the morning after the vaccine, almost 24 hrs
This spontaneous report was received from a registered nurse concerning an unspecified number of patients of unknown demographics. On an unknown date, unspecified number of patients were vaccinated with improperly stored doses of VAQTA (lot number, expiry date, dose and route unspecified). No concomitant therapy was reported. No symptoms were reported. This is one of the several reports from the same source. Additional information has been requested.
PATIENT HAD MODERNA COVID VACCINE,  Dose 1 date: 07/01/2021, Dose 2 date: 07/29/2021, AND TESTED POSITIVE TO COVID.
The next day: fatigue Two days later: no symptoms 8 days later: coughing in the morning, shortness of breath, fever 9 days later: no fever, no cough, no shortness of breath, new symptom: hives/rashes and itchiness 9-13 days later: hives/rashes and itchiness  Hives/rashes treated with benadryl/antihistamines
03/04/23 presents to ED for "shortness of breath, weakness". PMHx of "HTN, OSA"
3 hours after injection severe arm pain, very stiff on movement; progressively got worse throughout  night.  13 hours later SEVERE body aches worse at hips and low back, severe headache, chills with temp at  101.7. no energy and steadily declining throughout day. no appetite. Also felt very nauseous. Some  mild confusion  20 hours later chest pains  01-21-2020 body aches and headache improved. Very weak and shortness of breath.
Pt developed redness, swelling, pain, and fever the day after his vaccines, on left deltoid area where had Kinrix shot. Went to ED, diagnosed with cellulitis, started trim-sulfa.
Sore arm, terrible headache, neck pain, muscle soreness, chills, stomach ache, slight cough - started about 18 hours after shot and lasted around 12-24 hours
Experienced shoulder pain in left shoulder the night of vaccine. Progressivley worsened over several days. Saw ortho doc on March 18  and given Meloxicam and x-ray was performed (which was negative). Under ultrasound guidance a steroid injection was administered in the shoulder.
She developed redness swelling and itching from the injection site on her deltoid muscle down to her elbow. The actual onset of symptoms is not clear, but her mother contacted our office on 10/30/17.
arm hurt; no energy; body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt), ASTHENIA (no energy) and PAIN (body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurt), ASTHENIA (no energy) and PAIN (body aches). At the time of the report, PAIN IN EXTREMITY (arm hurt), ASTHENIA (no energy) and PAIN (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt), ASTHENIA (no energy) and PAIN (body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurt), ASTHENIA (no energy) and PAIN (body aches). At the time of the report, PAIN IN EXTREMITY (arm hurt), ASTHENIA (no energy) and PAIN (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
I noticed that my blood pressure had gotten high, it will not go down. I made an appointment to see my doctor to find out if there could be a reason that is causing my blood pressure to remain high. My doctor has changed my medications to see it this will help to bring my medication down to normal.
fever on 24MAR95 @ 1215AM to 105; tried w/APAP & tepid baths; to MD 24MAR95 in afternoon & sat t104 to MD;
Administered 5/5/12 - patient ran fever 5/5 and 5/6 - on 5/6 fever was 102 degrees - local Rx and rash.
3 days post vaccine red rash starting below injection site that developed into  multiple patches of vesicles down anterior surface of forearm onto palm and   between thumb and index finger and then 1 patch on dorsal surface of hand ..sore tender to touch resembling zoster in appearance and still present 10 days later
usual side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (usual side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (usual side effects). At the time of the report, VACCINATION COMPLICATION (usual side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
PATIENT CAME INTO CLINIC TODAY 9/7/21 WITH REPORTS OF A SWOLLEN LYMPH NODE UNDER LEFT ARMPIT.
1/2 hour after, right arm pain and tingling in fingers. 1 hour -2 hours after pain radiating down right arm to fingers. 12-14 hours after cold chills, sever body pain in joints, muscle, nerves. 14hours till 3 days after after sever pain still occurring along with joint stiffness, weakness, moderate fatigue. 4 days after mild overall pain with less weakness and stiffness with random times of pain radiating down different body parts.
Fever, chills, erythema, heat and swelling right upper arm.  11/13/2007 MR received for DOS 10/23-24/2007 with D/C Dx of Allergic Reaction to immunization with mostly local allergic reaction.  Temperature spike. Pt presented to ER with severe pain, heat and swelling in the R arm where flu and pnuemo vax given. Was given abx and d/c.  Later in the day she presented again with high fever, sweats and chills. T=104.2 after Tylenol and Motrin.  PE (+) for H/A, joint and back aches,  and R arm erythema, swelling and pain. (+) dehydration as well. Txd with abx, steroids, IVF and antihistamines with improvement. F/U appt 10/25 with pt feeling much better.
PT.RECEIVED DapTCELL VACCINE N L. DELTOID.AFTER 72HRS., PT. RETURNED TO OFFICE TO HAVE PPD READ & PARENT STATED INJ.SITE OF DapTCELL BECAME RED, SWOLLEN, & WARM TO TOUCH. ON EXAM ONLY SLIGHT PINK DEMARCATION. ALL PREVIOUS ADPT WERE TRIPEDIA
Swelling started within 2 hours at injection site, height of approximately 2cm, diameter approximately 7cm.  Swelling at injection site continued for 2 1/2 weeks.  Woke up at approximately 11PM disoriented, tightness of chest, difficulty taking full breath, extreme lightheadness upon standing, that got worse during standing.  Temporarily grayed out, fell to knees.  Got to sitting position and administered inhaler, took allergy medications.  After 15 minutes, symptoms started to abate to point felt comfortable walking.  Went to ER.  Upon arrival at ER pulse was at 144 and Oxygen Saturation was around 97%.  Normal EKG, High WBC at time at 18.7 K/uL, Abs neuts at 15.5K/uL, up from 5.8K/uL reading done on 2/21/2019, Abs immature grans at .1, and Abs monos at 1.3 K/uL.  Decadron administered, at 207 am on 3/22/2019.  Normal CMP except slightly heightened glucose at 117 mg/dL performed at hospital on 3/22/2019.  Continued to have episodes of tachycardia occur, no known trigger, worse during peak allergy season.  Continued episodes of tightness in the chest.
This case was reported by a nurse and described the occurrence of injection site burning in a female patient who received hepatitis B vaccine recombinant (Engerix B). On 11/19/2004, the patient received th e1st dose of Engerix B in the left arm (lot ENG5595BC incorrect lot number). At an unspecified time following the first administration of Engerix B, on 11/19/2004, the patient experienced an injection site reaction characterized as burning. The events resolved on 11/19/2004. The nurse reported that, the vaccine had just been removed from the refrigerator prior to the injection and it was cold. The nurse considered the injection site reaction to probably be related to vaccination with Engerix B.
This  73  year old white male received the 2nd Covid shot on   4/23    and died on   04/24/21.  Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation.
This spontaneous report was received from a nurse and refers to a 18 year old female patient. There were no concurrent conditions and medical history. The patient's concomitant therapies includes unspecified immunosuppressive medications. On an unknown date (reported as in "childhood"), the patient was vaccinated with a series of VARIVAX (dose, route, anatomical place of vaccination, lot# and expiration date were not provided), for varicella prevention. Approximately in 2017 (reported as "in the past year"), the patient developed an unspecified kidney disease (nephropathy) which now required a kidney transplant. On 08-JAN-2018, varicella titers were drawn and results showed negative (antibody test negative). Per nurse, treatment for this was to vaccinate with VARIVAX, however, it was unknown if the patient received another dose. The reporter stated that the patient had been managed as an outpatient and not yet been hospitalized but condition was potentially life threatening and disabling. The reporter did not know if patient had required dialysis. At the time of reporting, the patient did not recover from nephropathy and the outcome of antibody test negative was unknown. The reporter did not provide a causality assessment between nephropathy and antibody test negative and VARIVAX.
Dizziness, Headache, Arthralgia, extreme fatigue, chills Narrative:
Patient described onset of large 'orange sized' hot lump in the area of administration, onset was approx 72 hours after admin.  patient stated lump was hot to the touch but not painful.  patient denied systemic fever.  patient reports slight rash like appearance to the area as well.  all symptoms are subsided after ~2 days after onset.
Patient was in post vaccine waiting area and started to feel "throat become scratchy and a little thick with swallowing"  able to drink H2O without difficulty, given Zyrtec 10 mg po, Famotidine 20 mg po, no swelling, rash, shortness of breath or other symptoms.  Monitored for 1 hour,   O2 sats at 98%, lung clear, respirations even, unlabored.  states itchy throat resolved fully, thick felling is improved.  advised to follow up in ER if symptoms return
This spontaneous report was received from a physician via company representatives referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 16-JUN-2016, the patient was vaccinated with an improperly stored dose of VAQTA 25U/.5ML 10X1 (ped) (Lot # K012457, expiration date 04-JUN-2017) route, dose and anatomical location were not informed. Information regarding concomitant mediation was not provided. No adverse effects were reported. On an unknown date, the VAQTA had a temperature excursion for 96 hours, the lowest recorded temperature was 34 F (1.111111111 Celsius degrees). The vaccine status was reported as "in excursion", the storage criteria and the storage type were reported as "Refrigerator (R)". There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
We received a call the day after injection on 8/27. Pt's injection site became very swollen and painful. Pt tried BENADRYL and IBU without relief.
Parosmia (persistent burning smell) starting a few weeks after Comirnaty injection
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult male patient who received SHINGRIX for prophylaxis. Co-suspect products included INFLUENZA VACCINE for prophylaxis. On 24th August 2018, the patient received the 1st dose of SHINGRIX and INFLUENZA VACCINE. On 24th August 2018, less than a day after receiving SHINGRIX, the patient experienced injection site pain and shivering. On 24th August 2018, the outcome of the shivering was recovered/resolved. On 27th August 2018, the outcome of the injection site pain was recovered/resolved. It was unknown if the reporter considered the injection site pain and shivering to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient's wife. The patient received SHINGRIX in left arm and flu vaccine in right arm. Before being given the vaccines, the patient's wife did ask if there would be a problem with taking both vaccines together to the pharmacist. The reporter was told by the pharmacist that it should be fine. The reporter did not know if it could be from both vaccines or not. Later in the evening, the patient experienced shivering. He could not seem to get warm but it resolved later that night, she said. The manufacturer for the flu vaccine was Seqirus. This case has been linked with the case US2018157116, reported by the wife of the patient.
Caller reports no adverse effects to patient; VARIVAX administered IM rather than SQ; This spontaneous report was received from a medical assistant and refers to a 42-year-old female patient. Her medical history, concurrent conditions and concomitant therapies were not reported.  On 29-JUN-2022, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5ml/once (anatomical location, lot #, and expiry date were not provided) intramuscularly rather than subcutaneously (incorrect route of product administration). No adverse effects were reported. The reporter inquired if re-dosing was necessary.
Received LAIV Nasalmist of 2009 H1N1 prior to knowing I was pregnant.  12/1/09 OB/GYN records received, service dates 12/1/09. Assessment: Pregnant - Elderly multigravida. Office visit to confirm pregnancy.
Second Dose Scheduled for 55 days after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second Dose Scheduled for 55 days after the first dose) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concurrent medical conditions included Type 1 diabetes mellitus.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second Dose Scheduled for 55 days after the first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Second Dose Scheduled for 55 days after the first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.